Cargando…
Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells
Small‐Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy with a poor prognosis. Here, we focus on the neuroendocrine SCLC subtypes, SCLC‐A and SCLC‐N, whose transcription addiction was driven by ASCL1 and NEUROD1 transcription factors which target E‐box motifs to activate up to 40% o...
Autores principales: | Costanzo, Federico, Martínez Diez, Marta, Santamaría Nuñez, Gema, Díaz‐Hernandéz, Juan Ignacio, Genes Robles, Carlos Mario, Díez Pérez, Javier, Compe, Emmanuel, Ricci, Romeo, Li, Tsai‐Kun, Coin, Frédéric, Martínez Leal, Juan Fernando, Garrido‐Martin, Eva Maria, Egly, Jean Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988166/ https://www.ncbi.nlm.nih.gov/pubmed/35263037 http://dx.doi.org/10.15252/emmm.202114841 |
Ejemplares similares
-
TFIIE orchestrates the recruitment of the TFIIH kinase module at promoter before release during transcription
por: Compe, Emmanuel, et al.
Publicado: (2019) -
Ascl1b and Neurod1, instead of Neurog3, control pancreatic endocrine cell fate in zebrafish
por: Flasse, Lydie C, et al.
Publicado: (2013) -
The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein
expression in SCLC patients receiving platinum-based
chemotherapy
por: Tendler, Salomon, et al.
Publicado: (2020) -
Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
por: Lewis, Nichole A., et al.
Publicado: (2022) -
Lurbinectedin in small cell lung cancer
por: Manzo, Anna, et al.
Publicado: (2022)